文献速递脑血管病

循环DNA作为中性粒细胞胞外诱捕网标志物与癌症相关卒中:OASIS-Cancer研究

Circulating DNAs, a Marker of Neutrophil Extracellular Traposis and Cancer-Related Stroke: The OASIS-Cancer Study.
PubMed 文献 · Stroke · 2019-08-09

这项前瞻性队列研究纳入138例受试者,比较癌症相关卒中、健康对照、癌症对照和卒中对照的血浆DNA与核小体水平,发现癌症相关卒中患者血浆DNA和核小体显著升高且与D-二聚体相关,校正混杂因素后血浆DNA最高四分位与癌症相关卒中及D-二聚体≥2 μg/mL独立相关。

要点

  • 癌症相关卒中患者血浆DNA和核小体水平显著高于健康对照。
  • 血浆DNA水平与D-二聚体水平显著相关,提示与凝血异常相关。
  • 血浆DNA最高四分位与癌症相关卒中独立相关(OR=11.65)。

核心结论

  • 循环DNA水平升高与癌症相关卒中相关,提示NETosis可能是癌症相关卒中的分子机制之一。
  • 需进一步大样本长期随访研究确认NET特异性生物标志物的作用。

研究设计与样本

  • 前瞻性队列研究,共纳入138例患者。
  • 包括38例癌症相关卒中(活动性癌症合并急性隐源性栓塞性卒中)、33例健康对照、27例癌症对照(活动性癌症无卒中)和40例卒中对照(急性缺血性卒中无癌症)。
  • 以血浆DNA和核小体作为NET特异性生物标志物。

主要发现

  • 癌症相关卒中患者血浆DNA和核小体水平显著高于健康对照(P<0.05)。
  • 血浆DNA和核小体水平与D-二聚体水平相关(P<0.01)。
  • 多变量回归分析中,校正潜在混杂因素后,血浆DNA最高四分位与癌症相关卒中相关(OR=11.65;95% CI,3.199-42.46)。
  • 血浆DNA最高四分位与D-二聚体≥2 μg/mL相关(OR=19.09;95% CI,4.143-87.95)。

临床怎么用

  • 在活动性癌症合并隐源性栓塞性卒中患者中,可考虑检测血浆DNA和核小体作为NETosis相关生物标志物。
  • 血浆DNA升高与D-二聚体≥2 μg/mL相关,提示评估凝血异常时需关注NETs机制。

局限性

  • 研究为观察性设计,无法确立因果关系。
  • 样本量有限,需大样本长期随访研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- The role of circulating neutrophil extracellular traps (NETs) in cancer-related stroke is unknown. Methods- We conducted a prospective cohort study to test whether NETs are increased in cancer-related stroke and whether elevated NETs levels are associated with coagulopathy, assessed using D-dimer levels (≥2 μg/mL). Plasma DNA and nucleosome were assessed as NET-specific biomarkers. Results- In total, 138 patients were recruited; 38 patients had cancer-related stroke (active cancer and acute cryptogenic embolic stroke), 33 patients were healthy-controls, 27 patients were cancer-controls (active cancer but no stroke), and 40 patients were stroke-controls (acute ischemic stroke but no cancer). Plasma DNA and nucleosome levels were significantly elevated in cancer-related stroke patients than in healthy-controls (P<0.05). These levels were correlated with the D-dimer levels (P<0.01). In multiple regression analyses, increased plasma DNA levels were associated with cancer-related stroke (odds ratio=11.65 for highest quartile; 95% CI, 3.199-42.46) and D-dimer levels of ≥2 μg/mL (odds ratio=19.09 for highest quartile; 95% CI, 4.143-87.95) after adjusting for possible confounders. Conclusions- Increased circulating DNA levels were associated with cancer-related stroke, suggesting that NETosis is one of the molecular mechanisms of cancer-related stroke. Further long-term follow-up studies in large cohorts are needed to confirm the role of NET-specific biomarkers.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Bang OY, Chung JW, Cho YH, et al. Circulating DNAs, a Marker of Neutrophil Extracellular Traposis and Cancer-Related Stroke: The OASIS-Cancer Study. Stroke. 2019. PMID: 31394991. doi:10.1161/STROKEAHA.119.026373

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。